Lv3
368 积分 2023-09-18 加入
Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease Patients: A 7-Year Population-based Cohort Study
15天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
15天前
已完结
Triggers, Drivers, and Lids: Uncovering the Mechanistic Differentiators between IL-4– and IL-13–Targeted mAbs
18天前
已完结
Cutaneous adverse drug reactions
18天前
已完结
The ‘mono‐side’ of cutaneous adverse drug reactions
18天前
已完结
Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World Setting
19天前
已完结
Type 2 Inflammatory Phenotypes in Chronic Obstructive Pulmonary Disease and Asthma: Similarities and Differences
20天前
已完结
Treatable Traits in Airway Disease: From Theory to Practice
20天前
已完结
Dupilumab in real-life settings: a review of adverse events and their pathogenesis
20天前
已完结
Drug Reaction with Eosinophilia and Systemic Symptoms
20天前
已完结
皖公网安备34019202002308
